NS
INBS icon

NBC Securities’s Intelligent Bio Solutions INBS Stock Holding History

NBC Securities’s Portfolio INBS Stock Details INBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-264
Closed -$2.69K – 2862
2025
Q3 		$2.69K Buy
264
+29
+12% +$467 ﹤0.01% 2358
2025
Q2 		$4K Buy
+235
New +$3.38K ﹤0.01% 2157

Other funds holding INBS

UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
CW
Curio Wealth Annapolis, Maryland $322M AUM 16.26% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
National Bank of Canada
National Bank of Canada Montreal, Quebec, Canada $140B AUM 46.34% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.45B AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

NBC Securities's INBS Position: Q4 2025 in Review

NBC Securities sold out of Intelligent Bio Solutions (INBS) in Q4 2025, closing a stake of 264 shares — an estimated $2.69K sold.

NBC Securities first reported a position in INBS in Q2 2025 and held it in 2 quarters. The position peaked at $4K in Q2 2025. 7 funds tracked by Wall St. Rank hold INBS as of Q4 2025.

  • NBC Securities reported no remaining Intelligent Bio Solutions position as of Q4 2025 after selling out during the quarter.
  • NBC Securities sold 264 Intelligent Bio Solutions shares in Q4 2025, an estimated $2.69K.
  • NBC Securities first reported a position in Intelligent Bio Solutions in Q2 2025 and held it in 2 quarters.
  • NBC Securities's Intelligent Bio Solutions position peaked at $4K in Q2 2025.
  • 7 funds tracked by Wall St. Rank held Intelligent Bio Solutions as of Q4 2025.

Based on NBC Securities's 13F filing for Q4 2025, filed 29 Jan 2026.